Articles dans des revues avec comité de lecture (191)
  1. 145. Aaby, P., Shaheen, S. O., Heyes, C. B., Goudiaby, A., Hall, A. J., Shiell, A. W., Jensen, H., & Marchant, A. (2000). Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clinical and experimental allergy, 30(5), 644-650. doi:10.1046/j.1365-2222.2000.00803.x
  2. 146. Marchant, A., Goetghebuer, T., Ota, M. O., Wolfe, I., Ceesay, S. J., De Groote, D., Corrah, T., Bennett, S., Wheeler, J., Huygen, K., Aaby, P., McAdam, K. P., & Newport, M. J. (1999). Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. The Journal of immunology, 163(4), 2249-2255.
  3. 147. Jobe, O., Ariyoshi, K., Marchant, A., Sabally, S., Corrah, T., Berry, N., Jaffar, S., & Whittle, H. C. (1999). Proviral load and immune function in blood and lymph node during HIV-1 and HIV-2 infection. Clinical and experimental immunology, 116(3), 474-478. doi:10.1046/j.1365-2249.1999.00914.x
  4. 148. Ota, M. O., O'Donovan, D., Marchant, A., Yamuah, L., Harding, E., Jaffar, S., McAdam, K. P., Corrah, T., & Whittle, H. C. (1999). HIV-negative infants born to HIV-1 but not HIV-2-positive mothers fail to develop a Bacillus Calmette-Guérin scar. AIDS, 13(8), 996-998.
  5. 149. Friedman, G., Jankowski, S., Marchant, A., Goldman, M., Kahn, R., & Vincent, J. L. (1997). Blood interleukin 10 levels parallel the severity of septic shock. Journal of critical care, 12(4), 183-187. doi:10.1016/S0883-9441(97)90030-7
  6. 150. van der Poll, T., Marchant, A., & van Deventer, S. (1997). The role of interleukin-10 in the pathogenesis of bacterial infection. Clinical microbiology and infection, 3(6), 605-607.
  7. 151. van der Poll, T., Marchant, A., Keogh, C. V., Goldman, M., & Lowry, S. F. (1996). Interleukin-10 impairs host defense in murine pneumococcal pneumonia. The Journal of infectious diseases, 174(5), 994-1000.
  8. 152. Goldman, M., Marchant, A., & Schandené, L. (1996). Endogenous interleukin-10 in inflammatory disorders: regulatory roles and pharmacological modulation. Annals of the New York Academy of Sciences, 796, 282-293. doi:10.1111/j.1749-6632.1996.tb32590.x
  9. 153. Marchant, A., Amraoui, Z., Gueydan, C., Bruyns, C., Le Moine, O., Vandenabeele, P., Fiers, W., Buurman, W., & Goldman, M. (1996). Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clinical and experimental immunology, 106(1), 91-96. doi:10.1046/j.1365-2249.1996.d01-799.x
  10. 154. Gueydan, C., Houzet, L., Marchant, A., Sels, A., Huez, G., & Kruys, V. (1996). Engagement of tumor necrosis factor mRNA by an endotoxin-inducible cytoplasmic protein. Molecular medicine, 2(4), 479-488.
  11. 155. Le Moine, O., Stordeur, P., Schandené, L., Marchant, A., De Groote, D., Goldman, M., & Devière, J. (1996). Adenosine enhances IL-10 secretion by human monocytes. The Journal of immunology, 156(11), 4408-4414.
  12. 156. Marchant, A., & Goldman, M. (1996). OM-85 BV upregulates the expression of adhesion molecules on phagocytes through a CD 14-independent pathway. International journal of immunopharmacology, 18(4), 259-262. doi:10.1016/0192-0561(96)84505-X
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>